EcoDrugPlus

Cyclin Dependent Kinase 7

Ensembl ID : ENSVVUG00000006786
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSVVUG00000013275
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSVVUG00000013678
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSVVUG00000029487
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 3a12

Ensembl ID : ENSVVUG00000008658
Gene Symbol: LOC112909983
2 Cross references
468 Possible Orthologues:

Cytochrome P450 3a12-Like

Ensembl ID : ENSVVUG00000014002
Gene Symbol: LOC112935742
2 Cross references
457 Possible Orthologues:

Cytochrome P450 3a12-Like

Ensembl ID : ENSVVUG00000023227
Gene Symbol: LOC112935745
3 Cross references
456 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSVVUG00000004262
Gene Symbol: CYP17A1
4 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSVVUG00000018740
Gene Symbol: CYP19A1
4 Cross references
315 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSVVUG00000021829
Gene Symbol: CYP26A1
3 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSVVUG00000028382
Gene Symbol: CYP46A1
4 Cross references
259 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSVVUG00000006135
Gene Symbol: DGAT1
3 Cross references
260 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).